Over 3,500 new jobs will be created and 75,000 sq m of research and development and clinical space will be delivered at the Cambridge Biomedical Campus after proposals from joint developers Liberty Property Trust and Countryside were approved by Cambridge City Council.
The Campus is already a world-renowned centre of clinical and healthcare excellence and has been a growing life sciences hub since the early 1960s. The approved plans for the next phase of the campus will bring forward development of an additional 23 acres of land, carefully masterplanned with a ‘landscape first’ approach. Extensive consultation and engagement helped shape proposals for the expansion which will incorporate state-of-the-art research and development facilities alongside new clinical space for Cambridge University Hospitals, further enhancing this thriving and collaborative community.
The landscape led approach maximises the quality of the open spaces within the development, focusing these on generous courtyards across the site which will be accessible to all. The wider masterplan has been designed to promote and enhance connectivity and communication across the campus, fundamental to its collaborative ethos.
The Cambridge Biomedical Campus is strategically situated two miles south of the city centre and combines world-class biomedical research, patient care and education on a single site. Occupiers on the campus include Cambridge University Hospitals (Addenbrooke’s and The Rosie), the University of Cambridge School of Clinical Medicine, multiple Medical Research Council labs and units as well as the Laboratory of Molecular Biology, and, GlaxoSmithKline. Construction is also underway on a new global research and development centre and corporate headquarters for AstraZeneca and the new Papworth Hospital, a state-of-the-art facility for patients requiring heart and lung treatment.
Andrew Blevins, managing director of Liberty Property Trust, said: “The economic success of the City has taken a giant step forward with the emergence of the Cambridge Biomedical Campus, which is already a truly international centre of healthcare excellence. There remains a strong demand from research institutes and companies to join this life sciences cluster and this decision marks a significant stage in the evolution of the Campus.”
Bidwells, Savills and Creative Partnerships are acting for the developers.